A holistic and integrated approach to implementing cognitive pharmaceutical services

Ars Pharmaceutica

Volumn 51, Issue 2, 2010, Pages 69-88

  Benrimoj, S I ^a,b   Feletto, E ^a,b   Gastelurrutia, M A ^c   Martinez Martinez, F ^c   Faus, M J ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Change management; Cognitive pharmaceutical services; Community pharmacy; Implementation

Indexed keywords

ARTICLE; CHANGE MANAGEMENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COGNITIVE PHARMACEUTICAL SERVICE; CONSUMER; ECONOMICS; GOVERNMENT; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH SERVICE; HOLISTIC CARE; INTEGRATED HEALTH CARE SYSTEM; MARKETING; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDICATION MANAGEMENT SERVICE; NURSE; ORGANIZATION AND MANAGEMENT; PHARMACIST; PHARMACY; PHYSICIAN; QUALITY CONTROL; SPAIN;

EID: 78951488239     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Cipolle R, Strand L, Morley P. Pharmaceutical care practice. New York: McGraw-Hill Medical; 2004.
2. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-43.
3. World Health Organization. The World Health Report 2008: Primary health care now more than ever. Switzerland: World Health Organization; 2008:1-119. Available at: http://www.who.int/whr/2008/whr08-en.pdf [Accessed July 28, 2009].
4. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch. Intern. Med. 2003;163(22):2716-2724.
5. Wedel R, Kalischuk RG, Patterson E, Brown S. Turning Vision into Reality: Successful integration of primary healthcare in Taber, Canada. Healthcare Policy. 2007;3(1):80-95.
6. Crossen-Sills J, Toomey I, Doherty ME. Technology and Home Care: Implementing systems to enhance aging in place. The Nursing Clinics of North America. 2009;44(2):239-246.
7. UK Department of Health. Pharmacy in England: Building on strengths - delivering the future. England: UK Department of Health; 2008.
8. Culbertson V, Arthur T, Rhodes P, Rhodes R. Consumer preferences for verbal and written medication information. Ann Pharmacother. 1988;22(5):390-396.
9. Van Wijk BL. Effectiveness of Interventions by Community Pharmacists to Improve Patient Adherence to Chronic Medication: A Systematic Review. Ann Pharmacother. 2005;39(2):319-328.
10. Hersberger K, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes - evaluation of a campaign in Swiss community pharmacies. Pharm World Sci. 2006;28(3):171-179. (Pubitemid 44584052)
11. Cahill K, Stead L, Lancaster T. A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation. Drug Safety. 2009;32(2):119-135.
12. Hawksworth, Corlett, Wright, Chrystyn. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695-700.
13. Blenkinsopp A, Celino G, Bond CM, Inch J. Medicines use reviews: the first year of a new community pharmacy service. The Pharmaceutical Journal. 2007;278(24 February):218-223. (Pubitemid 46381047)
14. Richmond S, Morton V, Cross B, et al. Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract. 2010;60:e10-e19.
15. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003). 2006;46(2):133-147.
16. Odedina FT, Segal R, Hepler CD. Providing pharmaceutical care in community practice. J Soc Admin Pharm. 1995;12(4):170-180.
17. Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496-592.
18. Laubscher T, Evans C, Blackburn D, Taylor J, McKay S. Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications. Can Fam Physician. 2009;55(12):e69-e75.
19. Chen T, de Almeida Neto A. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29(6):574-576.
20. George J. Supplementary Prescribing: Early Experiences of Pharmacists in Great Britain. Ann Pharmacother. 2006;40(10):1843-1850.
21. Guignard E, Bugnon O. Pharmaceutical Care in Community Pharmacies: Practice and Research in Switzerland. Ann Pharmacother. 2006;40(3):512-517.
22. Snella KA, Trewyn RD, Hansen LB, Bradberry C. Pharmacist Compensation for Cognitive Services: Focus on the Physician Office and Community Pharmacy. Pharmacotherapy. 2004;24(3):372-388.
23. Benrimoj SI, Roberts AS. Providing patient care in community pharmacies in Australia. Ann Pharmacother. 2005;39(11):1911-7.
24. Costa S, Santos C, Silveira J. Community pharmacy services in Portugal. Ann Pharmacother. 2006;40(12):2228-2234.
25. García del Río R. Bélgica reforma su modelo de pago a la botica priorizando el seguimiento. Correo Farmacéutico. 2010.
26. Bond CM. Evolution and change in community pharmacy. London: Royal Pharmaceutical Society of Great Britain; 2003. Available at: http://www.rpsgb.org.uk/pdfs/chevcommphsyn.pdf [Accessed March 22, 2009].
27. Benrimoj SI, Feletto E, Wilson LK. Building Organisational Flexibility to Promote the Implementation of Primary Care Service in Community Pharmacy. Canberra: Australian Government Department of Health and Ageing; 2010. Available at: http://www.guild.org.au/research/4cpa-project-display.asp?id=1865 [Accessed March 15, 2010].
28. Dunphy DC, Palmer IC, Benrimoj SI, Roberts AS. Change management and community pharmacy. Sydney: The University of Technology, Sydney; 2004. Available at: http://www.guild.org.au/research/project-display.asp?id=273 [Accessed February 1, 2009].
29. Harris W, Rivers P, Goldstein R. The potential role of community pharmacists in care management. Health Soc Care Comm. 1998;6(3):196-203.
30. Bernsten C, Andersson K, Gariepy Y, Simoens S. A comparative analysis of remuneration models for pharmaceutical professional services. Health Policy. 2010;95(1):1-9.
31. World Health Organization. The role of the pharmacist in the health care system. Tokyo, Japan: World Health Organization; 1994.
32. Canadian Pharmacists Association. Blueprint for pharmacy, designing the future together. Canadian Pharmacists Association; 2009.
33. Hamilton S, Huby G, Tierney A, et al. Mind the gap between policy imperatives and service provision: a qualitative study of the process of respiratory service development in England and Wales. BMC Health Serv Res. 2008;8:248.
34. Chen TF, Crampton M, Krass IK, Benrimoj SI. Collaboration between community pharmacists and GPs in innovative clinical services - a conceptual model. J Soc Admin Pharm. 1999;16(3-4):134-144. (Pubitemid 30123720)
35. Skomo ML, Kamal KM, Berdine HJ. A Required Course in the Development, Implementation, and Evaluation of Clinical Pharmacy Services. Am J Pharm Educ. 2008;72(5).
36. Fincham JE. Pharmacy Curricula and Bellwether Changes in Payment for Pharmacy Practice Services. Am J Pharm Educ. 2005;69(3):392-393.
37. Greene RJ, Cavell GF, Jackson SHD. Interprofessional clinical education of medical and pharmacy students. Med Educ. 1996;30(2):129-133. (Pubitemid 26137881)
38. Raehl CL. Changes in Pharmacy Practice Faculty 1995-2001: Implications for Junior Faculty Development. Pharmacotherapy. 2002;22(4):445-462.
39. Coleman CI, Schlesselman LS, Lao E, White CM. Number and Impact of Published Scholarly Works by Pharmacy Practice Faculty Members at Accredited US Colleges and Schools of Pharmacy (2001-2003). Am J Pharm Educ. 2007;71(3).
40. Gastelurrutia MA, Faus MJ, Fernandez-Llimos F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005;39(12):2105-2109.
41. Bell JS, Väänänen M, Ovaskainen H, Närhi U, Airaksinen MS. Providing Patient Care in Community Pharmacies: Practice and research in Finland. Ann Pharmacother. 2007;41(6):1039-46.
42. Roberts AS, Benrimoj SI, Dunphy DC, Palmer IC. Community pharmacy: Strategic change management. Sydney: McGraw-Hill Medical; 2007.
43. Desselle SP, Zgarrick DP. Pharmacy Management: Essentials for all practice settings. New York: McGraw Hill; 2004.
44. Feletto E, Wilson L, Roberts A, Benrimoj S. Flexibility in community pharmacy: a qualitative study of business models and cognitive services. Pharmacy World & Science. 2010;32(2):130-138.
45. Munroe WP, Rosenthal TG. Implementing Pharmaceutical Care: Evolution vs. revolution. Am Pharm. 1994;NS34(4):57-67.
46. Porter ME. On Competition, Updated and Expanded Edition. Updated Expaned. Harvard Business School Press; 2008.
47. Holland R, Nimmo C. Transitions, Part 1: Beyond pharmaceutical care. Am J Health Syst Pharm. 1999;56(17):1758-1764.
48. Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. J Am Pharm Assoc (Wash). 1997;NS37(5):535-542. (Pubitemid 28010791)
49. Elwyn G, Taubert M, Kowalczuk J. Sticky Knowledge: A possible model for investigating implementation in healthcare contexts. Implement Sci. 2007;2:44.
50. Greenhalgh T, Robert G, Bate P, Macfarlane F, Kyriakidou O. Diffusion of Innovations in Health Services Organisations: A systematic literature review. Oxford: Blackwell Publishing; 2005.
51. Golden W, Powell P. Towards a definition of flexibility: in search of the Holy Grail? Omega. 2000;28(4):373-384.
52. Ackoff R. Towards flexible organizations: A multidimensional design. Omega. 1977;5(6):649-662.
53. Volberda HW. Organizational Flexibility: Change preservation. A flexibility audit & redesign method. Groningen: Wolters-Noordhoff; 1992.
54. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Measuring organizational flexibility in community pharmacy: Building the capacity to implement cognitive pharmaceutical services. Res Social Adm Pharm. 2010;In Press.
55. Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity to implement cognitive pharmaceutical services: Quantifying the needs of community pharmacies. Res Social Adm Pharm. 2009;In Press, Corrected Proof.
56. Indritz MES, Artz MB. Value Added to Health by Pharmacists. Soc Sci Med. 1999;48:647-660.
57. Venkataraman K, Madhavan S, Bone P. Barriers and facilitators to pharmaceutical care in rural community practice. J Soc Admin Pharm. 1997;14(4):208-219. (Pubitemid 28103704)
58. van Mil JWF, Schulz M, Tromp TFJD. Pharmaceutical Care, European Developments in Concepts, Implementation, Teaching, and Research: A review. Pharm World Sci. 2004;26(6):303-11.
59. Rossing C, Hansen EH, Krass IK. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacists. J Soc Admin Pharm. 2001;19(2):55-64. (Pubitemid 34568394)
60. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice Change in Community Pharmacy: Quantification of facilitators. Ann Pharmacother. 2008;42(6):861-8.
61. Gastelurrutia MA, Benrimoj SI, Castrillon CC, et al. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci. 2009;31(1):32-9.
62. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced Pharmacy Services, Barriers and Facilitators in Australia's Community Pharmacies: Australia's national database project. Int J Pharm Prac. 2007;15(3):185-191.
63. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing Cognitive Services in Community Pharmacy: a review of facilitators used in practice change. Int J Pharm Prac. 2006;14:163-170. (Pubitemid 44368350)
64. Christensen DB, Hansen RW. Characteristics of Pharmacies and Pharmacists Associated with the Provision of Cognitive Services in the Community Setting. Journal of the American Pharmaceutical Association. 1999;39(5):640-647.
65. Hopp TR, Klinke BO, Sorensen EW, Herborg H, Roberts AS. Implementation of cognitive pharmaceutical services in Danish community pharmacies - perceptions of strategists and practitioners. Int J Pharm Prac. 2006;14(1):37-49.
66. The Commonwealth of Australia. The fourth community pharmacy agreement. 2005. Available at: http://www.health.gov.au/internet/main/publishing.nsf/ Content/F7FBDB333D030BFFCA257 0C000003A44/$File/4cpacompilation.pdf.
67. Pharmaceutical Society of Australia. Pharmacy is your future. Are you part of it?. Pharmaceutical Society of Australia; 2009.
68. Ministerio de Sanidad y Consumo. Plan Estratégico de Política Farmacéutica para el Sistema Nacional de Salud Español. Madrid: Ministerio de Sanidad y Consumo; 2004.
69. Ministerio de Sanidad y Consumo - Dirección General de Farmacia y Productos sanitarios. Consenso en Atención Farmacéutica. Ars Pharmaceutica. 2001;42(3-4):221-241.
70. Chapman J, Roberts M, Stokes J. Final Report: Evaluation of the Quality Care Pharmacy Program. Australia: The Pharmacy Guild of Australia; 2005. Available at: http://beta.guild.org.au/research/project-display.asp?id=281 [Accessed July 23, 2009].
71. Blenkinsopp A, Tann J, Platts A, Allen J. Evaluation of feasibility and acceptability of a community pharmacy health promotion scheme - views of users and providers. Health Educ J. 2002;61(1):52-69. (Pubitemid 34462377)
72. Pouloudi A, Whitley EA. Stakeholder identification in inter-organizational systems: gaining insights for drug use management systems. Eur J Inf Syst. 1997;6(1):1-14.
73. Vuong T, Marriott JL. Potential role of the community liaison pharmacist: stakeholder views. Int J Pharm Prac. 2006;14(2):135-148.
74. Chen T, de Almeida Neto A. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29(6):574-576. (Pubitemid 47594181)
75. Brock K.A., Doucette W.R. Collaborative Working Relationships Between Pharmacists and Physicians: An Exploratory Study. J Am Pharm Assoc. 2004;44:358-365.
76. Van C, Krass IK, Mitchell B. General Practitioner Perceptions of Extended Pharmacy Services and Modes of Collaboration with Pharmacists. J Pharm Prac Res. 2007;37(3):182-186. (Pubitemid 47597531)
77. Whitehead P, Atkin P, Krass IK, Benrimoj SI. Patient drug information and consumer choice of pharmacy. Int J Pharm Prac. 1999;7:71-79.
78. Gastelurrutia M, Gil de San Vicente O, Erauncetamurgil O, Odriozola I, Fernández-Llimós F. Customers' expectations and satisfaction with a pharmacy not providing advanced cognitive services. Pharm World Sci. 2006;28(6):374-376.
79. Naik Panvelkar P, Saini B, Armour C. Measurement of patient satisfaction with community pharmacy services: a review. Pharm World Sci. 2009;31(5):525-537.
80. Hassell K, Rogers A, Noyce PR. Community pharmacy as a primary health and self-care resource: a framework for understanding pharmacy utilization. Health Soc Care Comm. 2000;8(1):40-49.
81. Oscanoa T. Servicio de Geriatría Hospital Almenara. Anales de la Facultad de Medicina, Universidad Nacional Mayor de San Marcos. Interacción medicamentosa en Geriatría. 2000;65:119-126.
82. Ministerio de Sanidad y Consumo - Dirección General de Farmacia y Productos sanitarios. Consenso sobre Atención Farmacéutica. 2002. Available at: http://www.msc.es/profesionales/farmacia/consenso/consenso. htm#indice [Accessed November 12, 2009].
83. Consejo General de Colegios Oficiales de Farmacéuticos. Plan Estratégico para el Desarrollo de la Atención Farmacéutica. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2003. Available at: http://www.portalfarma.com/pfarma/taxonomia/general/gp000030.nsf/ voDocumentos/73CCC 188B3FEE9D9C1256C4B00398D49/$File/INDICE.pdf [Accessed November 12, 2009].
84. Grupo de Expertos de Foro de Atención Farmacéutica. Documento de Consenso. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2008.
85. Sabater Hernández D, Silva Castro MM, Faus Dáder MJ. Método Dáder. Guía de Seguimiento Farmacoterapé utico. Tercera edición. Granada: Grupo de Investigación en Atención Farmacéutica; 2007.
86. Dualde E, Faus M, Santonja F, Fernandez-Llimos F. Effectiveness of a videoconference training course on implementing pharmacy services. Pharm World Sci. 2009;31(6):638-642.